Inform genomics, inc.   product pipeline analysis
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
411
On Slideshare
411
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Inform Genomics, Inc. - Product Pipeline AnalysisMarket Research Reports Distributor - Aarkstore.com have vast database on market research reports, companyfinancials, company profiles, SWOT analysis, company report, company statistics, strategy review, industryreport, industry research to provide excellent and innovative service to our report buyers.Aarkstore.com have very interactive search feature to browse across more than 2,50,000 business industryreports. We are built on the premise that reading is valuable, capable of stirring emotions and firing theimagination. Whether youre looking for new market research report product trends or competitive industryanalysis of a new or existing market, Aarkstore.com has the best resource offerings and the expertise to makesure you get the right product every time.
  • 2. Inform Genomics, Inc. - Product Pipeline AnalysisSummary Inform Genomics, Inc. (Inform Genomics) is a development stage pharmaceutical company. The develops medicine products for cancer supportive care and inflammatory diseases. Its development stage products include OnPART, transplant test and InPART. The OnPART, Oncology Preferences And Risk of Toxicity, is used for treatment decisions in patients who receive chemotherapy for colorectal, breast, lung, or ovarian cancer. The transplant product is used to determine an individual patients risk for developing oral and gastrointestinal mucositis due to high-dose chemotherapy regimens prior to autologous stem cell transplant for multiple myeloma. The InPART, is an inflammation product that determine an individual patient’s likelihood of responding to and developing side effects from common drug therapies for inflammatory bowel. Inform Genomics is headquatered in Boston, Massachusetts, the US. This report is a source for data, analysis and actionable intelligence on the Inform Genomics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
  • 3. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
  • 4. Reasons to Buy - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally. - Design and develop your product development, marketing and sales strategies. - Exploit M&A opportunities by identifying market players with the most innovative pipeline. - Develop market-entry and market expansion strategies. - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return. - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high- value products that your competitor would add in its portfolio? – identify, understand and capitalize.
  • 5. List of Tables 3 List of Figures 3 Key Facts 4 Inform Genomics, Inc. Pipeline Products by Equipment Type 5 Inform Genomics, Inc. Pipeline Products by Development Stage 6 Inform Genomics, Inc. Pipeline Products by Therapy Area 7 Inform Genomics, Inc. Pipeline Products by Trial Phase 9 Inform Genomics, Inc. Pipeline Products by Milestone Summary 10 InPART 12 InPART Product Status 12 InPART Product Description 12 OnPART 13 OnPART Product Status 13 OnPART Product Description 13 OnPART Product Milestone 13 OnPART Clinical Trial 15 Transplant Test 16 Transplant Test Product Status 16 Transplant Test Product Description 16 Inform Genomics, Inc. - Locations And Subsidiaries 17 Head Office 17 Appendix 18 Methodology 18 About GlobalData 18 Contact Us 18 Disclaimer 18
  • 6. List of Tables Inform Genomics, Inc., Key Facts 1 Inform Genomics, Inc. Key Pipeline Products by Equipment Type 1 Inform Genomics, Inc. Key Pipeline Products by Therapy Area 1 Inform Genomics, Inc. Key Pipeline Products by Development Stage 1 Inform Genomics, Inc. Key Pipeline Products by Trial Phase 1 Inform Genomics, Inc., Key Facts 4 Inform Genomics, Inc. Number of Pipeline Products by Equipment Type 5 Inform Genomics, Inc. Pipeline Products by Equipment Type 5 Inform Genomics, Inc. Number of Pipeline Products by Development Stage 6 Inform Genomics, Inc. Pipeline Products by Development Stage 6 Inform Genomics, Inc. Number of Pipeline Products by Therapy Area 7 Inform Genomics, Inc. Pipeline Products by Therapy Area 8 Inform Genomics, Inc. Number of Pipeline Products by Trial Phase 9 Inform Genomics, Inc. Pipeline Products by Trial Phase 9 Inform Genomics, Inc. Number of Pipeline Products By Milestone Summary 10 Inform Genomics, Inc. Pipeline Products by Milestone Summary 11 InPART - Product Status 12 InPART - Product Description 12 OnPART - Product Status 13 OnPART - Product Description 13 OnPART - Product Milestone 13 OnPART - First Phase Of Development For OnPART Personalized Medicine Product 15 Transplant Test - Product Status 16 Transplant Test - Product Description 16
  • 7. List of FiguresInform Genomics, Inc. Key Pipeline Products by Equipment Type 1Inform Genomics, Inc. Pipeline Products by Equipment Type 5Inform Genomics, Inc. Pipeline Products by Development Stage 6Inform Genomics, Inc. Pipeline Products by Therapy Area 7Inform Genomics, Inc. Pipeline Products by Trial Phase 9Inform Genomics, Inc. Pipeline Products by Milestone Summary 10
  • 8. Related ReportsFor more information, please visit:http://www.aarkstore.com/reports/Inform-Genomics-Inc-Product-Pipeline-Analysis-240200.htmlOr email us at contact@aarkstore.com or call +919272852585Related Reports• Competitive Intelligence: Leading Coagulation Market Players--Strategic Assessments of Major Suppliers and Emerging Ma• HeartSine Technologies, Inc. - Strategic SWOT Analysis Review• The Cooper Companies, Inc. (COO) - Financial and Strategic SWOT Analysis Review• Goold Health Systems, Inc. - Strategic SWOT Analysis Review• Atrium Medical Corporation - Strategic SWOT Analysis Review• iRhythm Technologies, Inc. - Strategic SWOT Analysis Review• Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review• Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review• Adpo Group NV - Strategic SWOT Analysis Review• Becton, Dickinson and Company (BDX) - Financial and Strategic SWOT Analysis Review
  • 9. Contact UsAarkstore E nterpriseT : +912227453309 elM obile No:+08149852585Email : contact@aarkstore.comW ebsite : http:/www.aarkstore.com /Blog: http:/www.emarketreports.com /http:/teju-aarkstoreenterprise.blogspot.in /Follow us on twitter: http:/twitter.com/ / aarkstoredotcomhttp:/in.linkedin.com/ aarkstore / in/http:/www.facebook.com/ / aarkstoreenterprise
  • 10. Contact UsAarkstore E nterpriseT : +912227453309 elM obile No:+08149852585Email : contact@aarkstore.comW ebsite : http:/www.aarkstore.com /Blog: http:/www.emarketreports.com /http:/teju-aarkstoreenterprise.blogspot.in /Follow us on twitter: http:/twitter.com/ / aarkstoredotcomhttp:/in.linkedin.com/ aarkstore / in/http:/www.facebook.com/ / aarkstoreenterprise